Fiala

Peptide library › Infections

Murepavadin

Also known as POL7080

In clinical trialsInfections

Experimental antibiotic designed to target Pseudomonas, the main lung infection in cystic fibrosis.

What people use it for

What Murepavadin does in the body

A ring-shaped peptide modelled on protegrin, a natural antimicrobial peptide. It blocks LptD, a protein Pseudomonas needs to build its outer membrane.

Strength of evidence

Limited: IV Phase 3 trials were stopped in 2019 because of kidney toxicity; an inhaled version is being developed.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

Investigational. Not approved by the FDA.

How it's taken

Route: Drip into a vein (halted) or inhaled (in development)

How long it lasts (half-life): Not well established in published data

Keep track of Murepavadin privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Murepavadin in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Infections